Leukocyte telomere length serves as the novel prognostic biomarker for the resectable NSCLC.

Sci Rep · 2025 · PMC12000439 · PMID 40234460

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

As cancer progresses, a clear trend toward a gradual decreasing of LTL was observed, particularly between stage I and stages II-IV (Fig.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.